Watchdog Calls On FDA To Set Policy For Use Of Unauthorized Tests In Public Health Emergencies
Executive Summary
The US Government Accountability Office reviewed how the FDA reviewed and monitored COVID-19 tests during the pandemic and found room for improvement. One particular concern was the lack of a straightforward policy on when enforcement discretion would be used.